According to the latest international clinical guidelines, statins remain the main group of drugs effective for the treatment of dyslipidemia and the prevention of cardiovascular disease (CVD) and complications. The article discusses the links of pathogenesis and mechanisms of damage to the cardiovascular system, analyzes the relationship with comorbidity, substantiates the need to search for effective and affordable therapeutic agents in the treatment of COVID-19. Statins have mechanisms of action that can affect the penetration of the virus into human cells, have an anti-inflammatory effect, improve the functional state of the vascular endothelium and reduce the risk of complications. The effectiveness of statins in patients with COVID-19 and high cardiovascular risk suggests that they need to be continued. In real clinical practice, priority should be given to effective and safe statins. Rosuvastatin is highly effective and safe, including a low risk of drug-drug interactions, and is the optimal therapeutic agent at all stages of cardiovascular prophylaxis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.